Indonesia’s sovereign wealth fund (SWF), known as INA, and a Chinese SWF are in talks to pick up a 20% stake in Indonesian pharmaceutical company PT Kimia Farma, according to a top executive.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
